A detailed history of Advisor Group Holdings, Inc. transactions in Neuronetics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 847 shares of STIM stock, worth $1,304. This represents 0.0% of its overall portfolio holdings.

Number of Shares
847
Previous 838 1.07%
Holding current value
$1,304
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$0.73 - $2.0 $6 - $18
9 Added 1.07%
847 $0
Q2 2024

Aug 13, 2024

BUY
$1.73 - $4.81 $1,449 - $4,030
838 New
838 $1,000
Q4 2023

Feb 12, 2024

SELL
$1.05 - $2.9 $1,312 - $3,625
-1,250 Reduced 28.11%
3,197 $9,000
Q3 2023

Nov 13, 2023

BUY
$1.29 - $2.22 $423 - $728
328 Added 7.96%
4,447 $6,000
Q2 2023

Aug 10, 2023

SELL
$2.07 - $2.92 $12 - $17
-6 Reduced 0.15%
4,119 $8,000
Q1 2023

May 12, 2023

SELL
$2.81 - $6.71 $2,340 - $5,589
-833 Reduced 16.8%
4,125 $12,000
Q4 2022

Feb 10, 2023

BUY
$2.74 - $6.87 $3,082 - $7,728
1,125 Added 29.35%
4,958 $34,000
Q3 2022

Nov 14, 2022

BUY
$2.35 - $4.66 $2,002 - $3,970
852 Added 28.58%
3,833 $12,000
Q2 2022

Aug 10, 2022

BUY
$2.09 - $3.71 $1,573 - $2,793
753 Added 33.8%
2,981 $9,000
Q1 2022

May 04, 2022

BUY
$2.84 - $4.52 $420 - $668
148 Added 7.12%
2,228 $7,000
Q3 2021

Nov 05, 2021

BUY
$6.22 - $15.54 $1,617 - $4,040
260 Added 14.29%
2,080 $14,000
Q2 2021

Aug 02, 2021

BUY
$10.15 - $17.25 $1,695 - $2,880
167 Added 10.1%
1,820 $29,000
Q1 2021

May 13, 2021

SELL
$10.6 - $21.27 $3,816 - $7,657
-360 Reduced 17.88%
1,653 $20,000
Q4 2020

Feb 10, 2021

BUY
$4.95 - $11.45 $608 - $1,408
123 Added 6.51%
2,013 $23,000
Q3 2020

Nov 12, 2020

BUY
$1.82 - $5.87 $910 - $2,935
500 Added 35.97%
1,890 $9,000
Q1 2020

May 18, 2020

BUY
$1.28 - $4.5 $1,779 - $6,255
1,390 New
1,390 $3,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $41.6M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.